Close Menu

This story has been updated from a previous version to include comments made by Qiagen executives during its earnings call.

NEW YORK (GenomeWeb) – Qiagen said after the close of the market on Monday that its fourth quarter revenues grew 2 percent year over year, falling short of the analysts' average estimate.

Qiagen also said this week that Genomics England has selected the Qiagen Clinical Insights portfolio on behalf of th National Health Service in England to support the UK's program to sequence, analyze, and interpret 5 million genomes over the next five years.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.